Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-propenamide, N-((3s,4s)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2h-pyran-4-yl)-
2. Blu-554
3. N-((3s,4s)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide
4. N-((3s,4s)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2h-pyran-4-yl)acrylamide
1. Blu-554
2. 1707289-21-1
3. Blu554
4. N-((3s,4s)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2h-pyran-4-yl)acrylamide
5. Blu111362
6. Fisogatinib [inn]
7. Fisogatinib [usan]
8. X439161
9. Blu-111362
10. 5q7r99ckv2
11. Blu 554
12. X-439161
13. 2-propenamide, N-((3s,4s)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl)amino)tetrahydro-2h-pyran-4-yl)-
14. N-((3s,4s)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)oxan-4-yl)prop-2-enamide
15. N-[(3s,4s)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl]amino]oxan-4-yl]prop-2-enamide
16. Blu554(fisogatinib)
17. Fisogatinib (usan/inn)
18. Unii-5q7r99ckv2
19. Fisogatinib [who-dd]
20. Blu 554 [who-dd]
21. Chembl4514636
22. Schembl16668287
23. Gtpl10220
24. Ex-a841
25. Amy16699
26. Bdbm50575072
27. Cs3008
28. Mfcd30496704
29. Nsc795718
30. S8503
31. Who 10947
32. Akos030632994
33. Ccg-269714
34. Cs-5986
35. Nsc-795718
36. Ac-29871
37. As-55934
38. Bb160379
39. Hy-100492
40. D11737
41. Q29209801
42. N-[(3s,4s)-3-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-quinazolinyl]amino]tetrahydro-2h-pyran-4-yl]-2-propenamide
| Molecular Weight | 503.4 g/mol |
|---|---|
| Molecular Formula | C24H24Cl2N4O4 |
| XLogP3 | 4.7 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | 502.1174606 g/mol |
| Monoisotopic Mass | 502.1174606 g/mol |
| Topological Polar Surface Area | 94.6 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 688 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
97
PharmaCompass offers a list of Fisogatinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fisogatinib manufacturer or Fisogatinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fisogatinib manufacturer or Fisogatinib supplier.
PharmaCompass also assists you with knowing the Fisogatinib API Price utilized in the formulation of products. Fisogatinib API Price is not always fixed or binding as the Fisogatinib Price is obtained through a variety of data sources. The Fisogatinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fisogatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fisogatinib, including repackagers and relabelers. The FDA regulates Fisogatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fisogatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fisogatinib supplier is an individual or a company that provides Fisogatinib active pharmaceutical ingredient (API) or Fisogatinib finished formulations upon request. The Fisogatinib suppliers may include Fisogatinib API manufacturers, exporters, distributors and traders.
Fisogatinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fisogatinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fisogatinib GMP manufacturer or Fisogatinib GMP API supplier for your needs.
A Fisogatinib CoA (Certificate of Analysis) is a formal document that attests to Fisogatinib's compliance with Fisogatinib specifications and serves as a tool for batch-level quality control.
Fisogatinib CoA mostly includes findings from lab analyses of a specific batch. For each Fisogatinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fisogatinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Fisogatinib EP), Fisogatinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fisogatinib USP).
